GASTRODUODENOSTOMY RISKS RESULTS
Category: General Surgery
Abstract : A gastroduodenostomy has many of the same risks associated with any other
major abdominal operation performed under general anesthesia, such as wound
problems, difficulty swallowing, infections, nausea, and blood
clotting. More specific risks are also associated with a
gastroduodenostomy, including: • Duodenogastric reflux, resulting in
persistent vomiting. •
A gastroduodenostomy has many of the same risks associated with any other
major abdominal operation performed under general anesthesia, such as wound
problems, difficulty swallowing, infections, nausea, and blood
clotting.
More specific risks are also associated with a
gastroduodenostomy, including: • Duodenogastric reflux, resulting in
persistent vomiting.
• Dumping syndrome, occurring after a meal and
characterized by sweating, abdominal pain, vomiting, lightheadedness, and
diarrhea.
• Low blood sugar levels (hypoglycemia) after a meal.
•
Alkaline reflux gastritis marked by abdominal pain, vomiting of bile, diminished
appetite, and iron-deficiency anemia.
• Malabsorption of necessary
nutrients, especially iron, in patients who have had all or part of the stomach
removed.
Normal results Results of a gastroduodenostomy are considered normal when
the continuity of the gastrointestinal tract is
reestablished. Morbidity and mortality rates For gastric
obstruction, a gastroduodenostomy is considered the most radical procedure. It
is recommended in the most severe cases and has been shown to provide good
results in relieving gastric obstruction is in most patients. Overall, good to
excellent gastroduodenostomy results are reported in 85% of cases of gastric
obstruction. In cases of cancer, a median survival time of 72 days has been
reported after gastroduodenostomy following the removal of gastric carcinoma,
although a few patients had extended survival times of three to four years.
Alternatives In the case of ulcer treatment, the need for a
gastroduodenostomy procedure has diminished greatly over the past 20–30 years
due to the discovery of two new classes of drugs and the presence of the
responsible germ (Helicobacter pylori) in the stomach. The drugs are the H2
blockers such as cimetidine and ranitidine and the proton pump inhibitors such
as omeprazole; these effectively stop acid production. H. pylori can be
eliminated from most patients with a combination therapy that includes
antibiotics and bismuth.
If an individual requires gastrointestinal reconstruction, there is no
alternative to a gastroduodenostomy.
Hit: 364 times
Related Articles in General Surgery :
|